New York City-based Memorial Sloan Kettering Cancer Center is partnering with AstraZeneca and Sophia Genetics to bring its proprietary liquid biopsy and solid tumor cancer tests to a global market, according to an Oct. 18 news release.
Read the full post on Becker's Hospital Review - Healthcare News
